THS de la menopausia y cáncer de mama. Estudio de 12 casos personales sobre una serie de 810 mujeres controladas 9 años. Comparación clínica con 20 casos de cáncer de mama sin THS

Vanrell, 1994, Carcinogénesis y tratamiento hormonal sustitutivo en la menopausia, Prog Obstet Ginecol, 37, 395 Simpson, 1988, Genesis of breast cancer in the premenopause, Lancet, 2, 74, 10.1016/S0140-6736(88)90007-4 Martin, 2003, Carcinogénesis genitomamaria, Prog Obstet Ginecol, 46, 502, 10.1016/S0304-5013(03)75939-1 Kingman, 2003, THS y cáncer de mama: últimos hallazgos, Orgyn, 1, 7 Adami, 1995, Hormone replacement and breast cancer, A remaining controversy? JAMA, 274, 178, 10.1001/jama.1995.03530020096039 Speroff, 1996, Postmenopausal hormone therapy and breast cancer, Obstet Gynecol, 87(2 Suppl), S44, 10.1016/0029-7844(95)00428-9 Becerra-Fernández, 2003, Abordaje farmacológico de la menopausia, Inf Ter Sist Nac Salud, 27, 105 Hulka, 1982, Breast cancer and estrogen replacement therapy, Am J Obstet Gynecol, 143, 638, 10.1016/0002-9378(82)90108-9 Wingo, 1987, The risk of breast cancer in postmenopausal women who have used estrogen replacement therapy, JAMA, 257, 209, 10.1001/jama.1987.03390020075030 Colditz, 1990, Prospective study of estrogen replacement therapy and risk of breast cancer in postmenopausal women, JAMA, 264,20, 2648, 10.1001/jama.1990.03450200056031 Bergkvist, 1989, The risk of breast cancer after estrogen and estrogen-progestin replacement, N Engl J Med, 321, 293, 10.1056/NEJM198908033210505 Newcomb, 1995, Long-term hormone replacement therapy and risk of breast cancer in postmenopausal women, Am J Epidemiol, 142, 788, 10.1093/oxfordjournals.aje.a117717 Kenemans, 1996, Hormone replacement therapy and breast cancer, Eur J Obstet Gynecol Reprod Biol, 67, 1, 10.1016/0301-2115(96)02425-6 Henderson, 1988, Re-evaluating the role of progestogen therapy after the menopause, Fertil Steril, 49(Suppl 5), S9 Bonnier, 1995, Clinical and biologic prognostic factors in breast cancer diagnosed during postmenopausal hormone replacement therapy, Obstet Gynecol, 85, 11, 10.1016/0029-7844(94)00324-7 Longnecker, 1996, Risk factors for in situ breast cancer, Cancer Epidemiol Biomarkers Prev, 5, 961 Steinberg, 1991, A metaanalysis of the effect of estrogen replacement therapy on the risk of breast cancer, JAMA, 265, 1985, 10.1001/jama.1991.03460150089030 Sillero-Arenas, 1992, Menopausal hormone replacement therapy and breast cancer: a metaanalysis, Obstet Gynecol, 79, 286 Delgado-Rodríguez, 1994, Terapia hormonal sustitutiva en la menopausia y riesgo de cáncer de mama. Un metaanálisis, Prog Obstet Ginecol, 37, 601 Laforest, 1994, L’hormonothérapie substitutive de la ménopause augmente-t-elle le risque de cancer du sein?, Rev Fr Gynécol Obstet, 89, 181 Le, 1996, Traitement hormonal substitutif de la ménopause et risque de cancer du sein, J Gynecol Obstet Biol Reprod, 25, 684 Persson, 1996, Cancer risk in women receiving estrogen-progestin replacement therapy, Maturitas, 23(Suppl), S37, 10.1016/0378-5122(96)01010-9 Ewertz, 1996, Hormone therapy in the menopause and breast cancer risk: a review, Maturitas, 23, 241, 10.1016/0378-5122(95)00977-9 Gambrell Jr., 1996, Hormone replacement therapy and breast cancer risk, Arch Fam Med, 5, 341, 10.1001/archfami.5.6.341 Weiss, 1996, Health consequences of short and long-term postmenopausal hormone therapy, Clin Chem, 42, 1342, 10.1093/clinchem/42.8.1342 Magnusson, 1996, Prognostic characteristics in breast cancer after hormone replacement therapy, Breast Cancer Res Treat, 38, 325, 10.1007/BF01806152 Willis, 1996, Estrogen replacement therapy and risk of fatal breast cancer in a prospective cohort of postmenopausal women in the United States, Cancer Causes Control, 7, 449, 10.1007/BF00052671 Tavani, 1997, Hormone replacement treatment and breast cancer risk: an age-specific analysis, Cancer Epidemiol Biomarkers Prev, 6, 11 Brinton, 1997, Hormone replacement therapy and risk for breast cancer, Endocrinol Metab Clin North Am, 26, 361, 10.1016/S0889-8529(05)70252-8 Bergkvist, 1996, Hormone replacement therapy and breast cancer. A review of current Knowledge, Drug Saf, 15, 360, 10.2165/00002018-199615050-00006 Duran, 1993, Terapéutica hormonal sustitutiva en la postmenopausia y carcinoma ductal in situ, Prog Obstet Ginecol, 36, 82 Escofet, 2002, THS y cáncer de mama oculto, Folia Clinica Obst Ginecol, 36, 26 Grady, 1992, Hormone therapy to prevent disease and prolong life in postmenopausal women, Ann Intern Med, 117, 1016, 10.7326/0003-4819-117-12-1016